| 1 |
32304723 | Antiviral efficacy against influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model. | 2020 Jun |
1 |
| 2 |
29793021 | Phosphoinositide 3-kinase p110α negatively regulates thrombopoietin-mediated platelet activation and thrombus formation. | 2018 Oct |
1 |
| 3 |
27913296 | Regulation of skeletal muscle insulin-stimulated signaling through the MEK-REDD1-mTOR axis. | 2017 Jan 22 |
1 |
| 4 |
23250956 | Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanoma. | 2013 Jan 2 |
1 |
| 5 |
23501104 | Blockade of the ERK pathway enhances the therapeutic efficacy of the histone deacetylase inhibitor MS-275 in human tumor xenograft models. | 2013 Apr 19 |
1 |
| 6 |
23954471 | The protective action of ketanserin against lipopolysaccharide-induced shock in mice is mediated by inhibiting inducible NO synthase expression via the MEK/ERK pathway. | 2013 Dec |
1 |
| 7 |
21501342 | SH3P2 is a negative regulator of cell motility whose function is inhibited by ribosomal S6 kinase-mediated phosphorylation. | 2011 May |
1 |
| 8 |
18614619 | Reduction of chronic allograft nephropathy by inhibition of extracellular signal-regulated kinase 1 and 2 signaling. | 2008 Sep |
1 |
| 9 |
17907188 | Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms. | 2007 Oct |
2 |
| 10 |
15967111 | A role for K-ras in conferring resistance to the MEK inhibitor, CI-1040. | 2005 Apr |
3 |
| 11 |
16267021 | Development of a conditional in vivo model to evaluate the efficacy of small molecule inhibitors for the treatment of Raf-transformed hematopoietic cells. | 2005 Nov 1 |
1 |
| 12 |
15171791 | Use of mitogenic cascade blockers for treatment of C-Raf induced lung adenoma in vivo: CI-1040 strongly reduces growth and improves lung structure. | 2004 Jun 1 |
3 |